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Expression of the chemokine receptor CXCR5 identifies B follicular helper T cells. In this issue of Immunity,
Morita et al. (2011) describe a heterogeneous circulating CXCR5+CD4+ B cell helper population overrepre-
sented in juvenile dermatomyositis patients.Central memory (Tcm) and naive T cells
populate T zones of secondary lymphoid
organs, by virtue of expression of the che-
mokine receptor CCR7, L-selectin, and
the integrin LFA-1. Tcm cells express IL-
2 but are not necessarily polarized to T
helper (Th) cell phenotypes. By contrast,
effector memory T (Tem) cells are mostly
polarized (Th1, Th2, and Th17 cells),
secrete cytokines abundantly, have lost
CCR7, and express receptors for chemo-
kines upregulated in inflamed nonimmune
parenchyma. In the past decade, B follic-
ular helper T cells (Tfh cells) have been
characterized as another type of CD4+
helper T cell that specifically differentiate
under the influence of the transcription
factor Bcl-6.
Tfh cells exhibit effector function (help
for B cells), and like other T effectors,
have downregulated CCR7. Despite this,
they are disproportionately located in
secondary lymphoid organs rather than
inflamed nonlymphoid parenchyma, but
specifically within follicles rather than
T zones (Campbell et al., 2003). This is
due to loss of CCR7 and expression of
CXCR5, the receptor for CXCL13, which
is expressed constitutively by follicular
stroma. CXCR5 is expressed by all
mature B cells and by a small proportion
of memory T cells, but the highest expres-sion of CXCR5 is found on Tfh cells. Tfh
cells secrete predominantly IL-21 and
IL-4 and lesser amounts of IFN-g and
IL-17 (Yu and Vinuesa, 2010). To compli-
cate matters further, there appears to be
another population of T cells that is
dependent on Bcl6, exhibits Tfh cell-like
activity, but is located in extrafollicular
plasma cell foci (Poholek et al., 2010). In
this issue of Immunity, Morita et al.
(2011) identify a subset of circulating
CXCR5+ T cells with potent B cell helper
activity.
The ontogeny of Tfh cells remains
unknown. It is not clear whether they
differentiate from T cells shortly after
priming, or whether early Th1, Th2, and/or
Th17 cells can adopt follicular differentia-
tion upon exposure to cytokines such as
IL-6 and IL-21 in mice and IL-12 in
humans. Their relation to CXCR5+ T cells
in blood also remains uncertain. These
cells are absent from the blood in patients
lacking ICOS, which suggests that they
are related to Tfh cells (Bossaller et al.,
2006). This is also supported by their
abundance in mouse models character-
ized by excessive Tfh cell production in
secondary lymphoid tissues (Simpson
et al., 2010). It is possible that T cells
with intermediate expression of CXCR5,
shown to be potent IFN-g and IL-17producers (Yu and Vinuesa, 2010), could
be precursors of GC Tfh cells (Figure 1).
Earlier work showed that in humans,
CXCR5+ cells appear in the blood shortly
after immunization, and CXCR5 is
induced rapidly by naive and CD27+
memory cells (but not CD27 Tem cells)
(Schaerli et al., 2001). Compared with
their tonsillar counterparts, circulating
CXCR5+ T cells appeared to offer little
support for antibody production in cocul-
ture with autologous B cells in the
absence of exogenous antigen (Schaerli
et al., 2000).
Now, Morita et al. (2011) report that
CXCR5+ T cells from human peripheral
blood provide better help to B cells than
their CXCR5 counterparts. Circulating
CXCR5+ T cells are shown to be more
effective in providing help to naive B cells
at least in the presence of the superanti-
gen staphylococcal enterotoxin B (SEB)
(Morita et al., 2011). In coculture, B cells
differentiate into plasmablasts and
produced Ig within 6 days, in an
IL-21- and ICOS-dependent manner. By
contrast, CXCR5 populations are unable
to induce any switched Ig and only small
amounts of IgM. Furthermore, consistent
with previous findings (Schaerli et al.,
2001), the CXCR5+ cells sampled from
patients not recently vaccinated made
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Figure 1. Model of CD4+ T Cell Subsets
After priming, several T cell memory phenotypes have been identified. T cell subsets are classified accord-
ing to expression of CXCR5 and CCR7 (indicated by each quadrant) and location. Tcm (T central memory),
Tfh (follicular helper T), and Tem (T effector memory) cells all contain subsets capable of secreting IL-4,
IFN-g, and IL-17 to different extents. Most Tem cells are thought to have differentiated into cytokine-
secreting cells and express receptors for inflammatory chemokines. Morita et al. (2011) compare CXCR5
(solid black outline) and CXCR5+ (solid red outline) Tcm cells and demonstrate that the latter provide help
to B cells, except for the subset that is Th1 cell-like. T cell help is associated with IL-21 expression (and
CXCL13 expression). Bone fide follicular helper T cells are found in germinal centers (secondary follicles).
The precursor-progeny relations between most of the effector memory T cell subsets remain unknown.
pre-Tfh, Tfh cell precursors; TLO, tertiary lymphoid organs that occur in inflamed tissues and harbor
ectopic germinal centers.
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Previewsa more vigorous response than CXCR5
T cells to influenza virus and cytomegalo-
virus, reflecting a memory phenotype.
Although this study does not compare
CXCR5 expression from blood and
secondary lymphoid organs from the
same individual, it has previously been
shown that CXCR5+ cells are 100-fold
more abundant in tonsil than blood (as
a fraction of CD4+ T cells), and within the
CXCR5+ subset, CXCR5 expression in
tonsil is 10-fold higher per cell than in
blood (Simpson et al., 2010). Circulating
CXCR5+ T cells express lower ICOS than
tonsillar Tfh cells and lack Bcl-6 expres-
sion (Schaerli et al., 2000; Morita et al.,
2011). Morita et al. (2011) also show that
CXCR5+ cells express less Blimp-1
mRNA than their CXCR5 counterparts.
Morita et al. (2011) subclassify CXCR5+
T cells according to receptors for inflam-
matory chemokines, whose expression
is typical of Tem cells. A Th2 cell-like
CXCR5+CXCR3CCR6 subset coex-
presses the transcription factor Gata-3,
produces the typical Th2 cytokines—IL-4,IL-5, and IL-13—and provides help for
B cell production of all Ig classes
(including IgE) via IL-21 and IL-4. A third
Th17 cell-like CXCR5+CXCR3CCR6+
subset coexpresses the Th17 cytokines
IL-17A and IL-22 and provides help to
B cells via IL-21 production, resulting in
IgA, IgM, and IgG, but not IgE, production.
A ‘‘Th1 cell-like’’ CXCR5+CXCR3+CCR6
subset expresses the transcription factor
T-bet and produces IFN-g but is distinctly
unable to provide help to either naive or
memory B cells.
The inability of circulating CXCR5+ Th1-
like cells to help B cells is puzzling. It has
been known for some time that IFN-g
does not influence human isotype switch-
ing and this is clearly different in mice, in
which IFN-g is a potent switch factor for
IgG2a. Mouse IgG2a binds with high
affinity to activating Fc-g receptors. Th1
cell-like CXCR5+ cells express little
IL-21, and this suggests that the ability
to secrete IL-21 and CXCL13 distin-
guishes CXCR5+ and CXCR5 T cell
subsets. As shown in this study and re-Immunity 3ported by others, IL-21 is critical for the
observed plasmablast differentiation,
immunoglobulin production, and isotype
switching. CXCL13 is important to attract
CXCR5-expressing cells including B cells
and may therefore contribute to stabilize
cognate interactions.
These findings together with other
recent progress still raise important ques-
tions about how immunological memory
and effector responses are organized. Is
immunological memory distributed or
shared? In other words, if antigen reaches
a lymph node via the afferent lymphatics,
do Tfh cells remain localized there until
the next encounter with antigen, or do
they populate other secondary lymphoid
organs? If each LN is the repository of
a unique population of Tfh cells (distrib-
uted memory), how is information shared
throughout the immune network in order
to generate effector responses? Alterna-
tively, if circulating CXCR5+ T cells can
become Tem cells, mediating tissue
inflammation, and readily provide help to
B cells, this would appear to provide
a mechanism for shared memory.
These questions demand a better
understanding of the precursor-progeny
relations between the T cell subsets con-
cerned. For example, do circulating
CXCR5+ T cells develop in a Bcl-6-depen-
dent manner and are they therefore
related to bona fide Tfh cells? Do they
originate from pre or post GC Tfh cells,
or both? In a manner akin to the genera-
tion of memory CD8+ T cells, it is possible
that circulating memory CXCR5+CD4+
T cells emerge both from recently acti-
vated T effector cells prior to terminal
differentiation into GC Tfh cells and also,
albeit to a lesser extent, after contraction
of GCTfh cells (Figure 1). Thus, upon invo-
lution of GCs and Tfh cell apoptosis,
a small fraction of Tfh cells may differen-
tiate into a circulating memory subset
because of downregulation of Bcl-6 that
would allow downregulation of CXCR5
and upregulation of CCR7.
Finally, recent findings point to the
possibility that abundance of Tfh or Tfh-
related cells in the blood can be a signa-
ture of immune-mediated pathology. In
mice, it has been possible to demonstrate
a causal relation between excessive Tfh
cells and autoimmunity, autoantibody
production, and lupus nephritis (Linter-
man et al., 2009). In humanswith systemic
lupus erythematosus, increased numbers4, January 28, 2011 ª2011 Elsevier Inc. 11
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CXCR5+PD-1hi) cells have been shown
to associate with disease severity in
a subset of patients (Simpson et al.,
2010). Morita et al. (2011) show that in
juvenile dermatomyositis (JDM), an auto-
immune disease characterized by skin
and muscle inflammation, circulating
CXCR5+ T cells with Th2 and Th17 cell-
like characteristics are overrepresented.
Because the ratio of CXCR5+ Th2+Th17
to Th1 cells correlates closely with clinical
indicators of disease severity (rash and
muscular weakness) and because these
CXCR5+ subsets are potent B cell
helpers, this points to a possible
pathogenic connection. However, the
autoantibody response to JDM is not
well characterized, nor is the pathogenic
potential of the autoantibody response.
The plasticity of the CXCR5+ T cell pop-
ulation described here raises the possi-
bility that tissue recruitment causes
inflammation, while autoantibody
responses are an epiphenomenon medi-12 Immunity 34, January 28, 2011 ª2011 Elsated by recruitment of Th2- and Th17-
like CXCR5+ cells. If confirmed, this could
provide an important insight into the high
incidence of autoantibodies in autoim-
mune diseases, where the target autoan-
tigens for these autoantibodies arise
from the inflamed tissue, yet the autoanti-
bodies do not appear to be pathogenic.
Another possibility is that T cells that can
respond to inflammatory chemokines
and also provide B cell help might
contribute to tertiary lymphoid tissue,
which is characteristic of many autoim-
mune diseases (Figure 1). Much more
work is required to determine whether
these mechanisms hold, but the potential
pay-off is identification of early markers of
diseases and novel therapeutic targets.REFERENCES
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